ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 165714 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 165714; 2) Community: the network communities that were significantly associated with the response to NSC 165714; 3) Molecule: the relationships between components within communities and NSC 165714; 4) MDR: the compounds that were significantly associated with the NSC 165714.

NSC Compound Enrichment Correlation
NSC 627778 Null 0.0309214021749421 0.072451994
NSC 653624 Null 0.0309214021749421 0.10635454
NSC 671184 Null 0.0309214021749421 0.14348188
NSC 702338 4-Thiazolidinone, 3-(4-chlorophenyl)-2-(3,4,5-trimethoxyphenyl)- 0.0309214021749421 0.13098465
NSC 734977 Ethyl N-[4-(10-methyl-3-phenyl-4H-indolo[3,2-e][1,2,3]triazolo [1,5-a]pyrimidin-4-yl)butanoyl]glycinate 0.0309214021749421 0.1608529
NSC 747452 3,19-(4-Acetamido)benzylidineandrographolide 0.0309214021749421 0.21601603
NSC 679528 Null 0.0354217693930252 -0.12528675
NSC 727680 MMP-9/MMP-13 Inhibitor l CalBioChem Cat. No. 444252 0.0354217693930252 0.089755947
NSC 755289 (4-(2-(furan-2-ylmethylamino)benzoyl)piperazin-1-yl)(2-phenyl-7-(3,4,5-trimethoxyphenyl)pyrazolo[1,5-a]pyrimidin-5-yl)methanone 0.0354217693930252 0.71022173
NSC 760951 Null 0.0354217693930252 0.6471455
Total:17  Current:11    [First] [Prev] [Next] [Last]